The deficiency or downregulation of p57kip2 expression have been observed in multiple cancers including lymphomas [7], gastric cancer [8], pancreatic cancer [9], breast cancer [10], bladder cancer [11], and prostate cancer [12]. This evidence concerns the gene CDKN1C and pancreatic neoplasm.